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The evolving and complicating drug resistance exhibited by strains of Plasmodium falciparum to 
existing antimalarials like chloroquine and quinine (which are relatively more affordable than recent 
drugs) and advances in metal-drug complex research instigated this work. The antiplasmodial activity 
of the Quinine-Zinc complex (QZ) synthesized by a modification of the method of Singla and Wadhwa 
was assessed relative to that of Chloroquine diphosphate (C) in vitro. Measurement of antiplasmodial 
activity was carried out based on the inhibition of parasite growth measured by the inhibition of 
schizont formation in freshly collected infected blood samples from malaria patients. A comparative 
analysis of the antiplasmodial activity of QZ against C showed that its antiplasmodial activity was 
significantly better than that of C (p < 0.05). The result of this study suggests that the QZ could have a 
better therapeutic activity against malaria than C.  
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INTRODUCTION 
 
Malaria today accounts for more than 90% of deaths, has 
a record of about 300 to 500 million infections yearly and 
kills about 1.5 to 2.7 million people yearly (Goods, 2001; 
Sachs and Malaney, 2002). Malaria is one of the most 
common infectious diseases and an enormous public 
health problem. The disease is caused by protozoan 
parasite of the genus Plasmodium.  Five species of the 
plasmodium parasite can infect humans; the most serious 
forms of the disease are caused by Plasmodium 
falciparum. Malaria caused by Plasmodium vivax, 
Plasmodium ovale and Plasmodium malariae causes 
milder disease that is not generally fatal in humans. A 
fifth species Plasmodium knowlesi, causes malaria in 
macaques and can also infect humans. This group of 
human- pathogenic Plasmodium species is usually 
referred to as malaria parasites. 
The  efficiency  of  the  malaria  parasite  in  developing  
 
 
 
*Corresponding author. E-mail: kellybee2001@yahoo.com.  
resistance to antimalarials including even recently 
discovered drugs is the most disturbing issue related to 
malaria research. Today, malaria parasite has been 
confirmed to show notable resistance to inexpensive 
drugs like chloroquine, quinine, sulphadoxine/ 
pyrimethamine and a number of other inexpensive drugs, 
leaving us with newer drugs which cost 7 to 60 times 
more (Olliaro et al., 1996).  
The resistance of malaria parasite to almost all 
antimalarials has led scientific researchers into the 
exploitation of plant materials for the treatment of malaria. 
Since many drugs for example, quinine and artemisinin 
were isolated from plants, investigation of active 
components of plants has gained prominence (Phillipson, 
1991). Many of these bioactive phytochemicals may not 
have been thoroughly studied for toxicity and interaction 
with other xenobiotics. 
Zinc is becoming a topic of interest to scientific 
researchers in our times. Within therapeutic dosage, it is 
not known to cause any immediate side effects 
(Sandstead, 1995; Fosmere, 1990). On the contrary, usage  
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Figure 1. Bar Chart of Schizont count against drug concentration. 
 
 
 
of zinc over a long time has been shown to be beneficial 
in pregnancy (Goldenberg et al., 1995), dermatological 
issues like acne (Cunliffe et al., 1979), sickle cell 
anaemia (Gupta and Chanbey, 1995), ulcers (Frommer, 
1995) and in sickness (Marshall, 1998, Muller et al., 
2001).  
The antiplasmodial activity of QZ in vitro has been 
investigated and reported (Ogunlana et al., 2009). This 
work was designed to compare the antiplasmodial activity 
of a complex of two well-studied, readily available 
substances, quinine and zinc (Quinine-zinc complex) with 
that of Chloroquine diphosphate in vitro. 
 
 
MATERIALS AND METHODS 
 
Quinine-zinc complex had been synthesized and its synthesis has 
been authenticated by melting point determination, thin-layer 
chromatography (TLC) analysis, infra red, ultra violet, atomic 
absorption spectroscopy in our previous work (Ogunlana et al., 
2009). The mole ratio of quinine to zinc in the Quinine-zinc complex 
was also determined in our previous work (Ogunlana et al., 2009). 
This work was carried out in the laboratory of the Pharmaceutical 
Chemistry department, University of Ibadan, Oyo state, Nigeria, and 
the Institute of Medical Research and Training (IMRAT), College of 
Medicine, University of Ibadan, Oyo state, Nigeria. 
 
 
Culture procedure 
 
Cultivation of P. falciparum from positive blood samples collected 
from malaria parasites infected individuals, pre-harvest analysis of 
cultures, harvesting and analysis of post culture slides were carried 
out using the methods of Trager and Jenson (1976) and Jenson 
and Trager (1977) as reported in our previous work (Ogunlana et 
al., 2009). 
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Comparative determination of antimalarial activity of QZ and 
chloroquine 
 
In vitro test 
 
World health organization (WHO) standard micro in vitro 
susceptibility (MARK II) technique (WHO, 1990) was used to 
determine the in vitro sensitivity of P. falciparum to the QZ and C 
drugs. The test kits were obtained in IMRAT. 0.0111 g of C was 
dissolved in 500 ml distilled water (Stock solution1). 1 ml of Stock 
solution 1 was drawn with pipette into 10 ml falcon tube and made 
up to 10 ml with complete medium (Stock solution 2). Series of 
dilution of stock solution 2 were used to obtain 150 µl of samples 
containing 1, 2, 4, 8, 16, 32, 64, 128, 160, 256, 320, 620, 1280, 
2560 pmols of C and used to medicate wells in the columns labeled 
1 and 7 of B-H and B1-H1 containing 50 µl of culture medium. 
0.0128 g of QZ was dissolved in 100 ml water and similar 
procedure as that used for the preparation of different dilutions of C 
was followed to obtain same concentrations of QZ as that of C in 
pmols and used to medicate wells in columns labeled 5 and 11 of 
the micro plate. 200 µl of complete culture medium was used to 
medicate wells in row labeled A in the columns as control. The 
experiment was carried out in duplicates. 
Schizont inhibition and maturation were assessed in each well 
and the data obtained from the wells were processed to determine 
comparative sensitivity or resistance of P. falciparum to the drugs. 
 
 
Statistical analysis 
 
Students T-test was used for analysis of data for statistical 
significance at 95% significance level (p < 0.05). 
 
 
RESULTS 
 
From the graph of percentage schizont inhibition versus 
drug concentration shown in Figure 3, the minimum 
inhibitory concentration (MIC) of C was 2560 pmol/200 µl 
while that of QZ was 640 pmol/200 µl, indicating that the 
amount of QZ required for effective schizonticidal action 
was three times less than that of C. Drug concentration 
corresponding to 50% schizont inhibition (IC50) for QZ 
and C were 3.98 and 3.35 pmol/200 µl of drugs, 
respectively. Schizonticidal activity of QZ was 
significantly higher than that of C (p < 0.05). It is 
important to note that from Figures 1, 2 and 3, at 
concentrations lower than 128 pmol/200 µl, C exhibited 
better efficiency at inhibiting schizont growth. However, at 
drug concentrations of 128 pmol/200 µl, QZ showed 
better efficiency at inhibiting schizont growth or 
maturation. Hence schizont inhibition was better in the C-
medicated wells than the QZ-medicated wells at 
concentrations less than 128 pmol/200 µl but schizont 
maturation was better inhibited in the QZ- medicated 
wells than the C- medicated wells for drug concentrations 
greater than 128 pmol/200 µl.  
 
 
DISCUSSION 
 
From the result shown in Figure 1, the parasite was found 
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Figure 2.  Graph of percentage Schizont maturation against drug 
concentration. 
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Figure 3.  Graph of percentage Schizont inhibition against drug 
concentration. 
 
 
 
to be resistant to chloroquine because there was schizont 
growth at 8 pmol/200 µl and above. Parasite growth at 8 
pmol/200 µl and above is an indication of resistance 
(WHO, 1990). The parasite was however sensitive to 
both C and QZ with complete schizont inhibition at 2560 
and 640 pmol/200 µl, respectively. The report of Obaleye 
et al. (2009) on the increased antimalarial activity of 
some   quinolinemethanol    complexes    compared   with 
 
 
 
 
chloroquine and parent ligands corroborated the current 
findings. The antimalarial activity of 7-chloro-4-(1, 4, 7, 
10-tetraaza-cyclododec-1-yl)-quinoline-Zn
2+
 complex as 
well as other 7-chloro-4-aminoquinoline complexes 
between strong to moderate activities have also been 
reported (Khan et al., 2009).  
Although the exact mechanism of action of QZ is 
unknown, the report of Chevion et al. (1995) supports the 
reasoning that the higher schizonticidal activity of QZ 
compared to that of C may not be unconnected with 
better permeability of parasite erythrocyte to QZ than that 
of C and the possibility of the exchange of zinc metals in 
QZ for ferric ions, thus, rendering the iron unavailable for 
vital parasite functions. It has also been demonstrated 
that metal complexes mediate antimalarial activity by 
inhibiting hemozoin formation through binding to a dimer 
of hematin (Dorn et al., 1998) and as a result, might lead 
to accumulation of heme thereby, preventing 
intraerythrocytic growth and proliferation of the malaria 
parasite.  
 
 
Conclusion 
 
From in vitro micro test determination, complex was 
confirmed to have 3- times antimalarial potency over 
Chloroquine diphosphate. However, before Quinine Zinc 
complex can be recommended as a better alternative to 
chloroquine and its various salts forms, its acute toxicity 
levels in vivo must be tested and established. Further 
research is also required to establish its therapeutic 
advantage with the use of well characterized susceptible 
and resistant strains of malaria parasite. 
 
 
ACKNOWLEDGEMENTS 
 
The authors wish to appreciate the staff of the Institute of 
Medical Research and Training, College of Medicine, 
University of Ibadan, Oyo state, Nigeria for all their 
support and cooperation throughout the duration of this 
research. Our gratitude also goes to the academic and 
non- academic staff of the Department of Pharmaceutical 
Chemistry, University of Ibadan, Oyo state, Nigeria for all 
their support. 
 
 
REFERENCES 
 
Chevion M, Chuang L, Golenser J (1995). Effect of zinc-
desferrioxamine on Plasmodium falciparum in culture. Antimicrob. 
Agents Chemother., 39(8):  1902-1905.  
Cunliffe WJ, Burke B, Dodman B (1979). A double-blind trial of zinc 
sulphate/citrate complex and tetracycline in the treatment of acne 
vulgaris. Br. J. Dermatol., 101: 321-325.  
Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG 
(1998). An assessment of drug-haematin binding as a mechanism for 
inhibition of haematin polymerisation by quinoline antimalarials. 
Biochem. Pharm., 55: 727-736.  
Fosmere GJ (1990). Zinc toxicity. Am. J. Clin. Nutr., 51:  225-227.  
 
 
 
 
Frommer DJ (1975). The healing of gastric ulcers by Zinc sulphate. 
Med. J. Aust., 2:  96-793.  
Goldenberg RL, Tamura T, Neggers Y (1995). The effect of zinc 
supplement on pregnancy outcome. J. Am. Med. Assoc., 274: 750-
762.  
Good MF (2001). Towards a blood-stage vaccine for malaria: are we 
following all the leads? Nat. Rev. Immunol., 1: 117-125.  
Gupta VL, Chanbey BS (1995). Efficacy of zinc therapy in prevention of 
crisis in sickle cell anemia: a double blind randomized controlled 
clinical trial. J. Assoc. Phys. India, 43: 467-469.  
Jenson JB, Trager W (1977). Plasmodium falciparum in culture: use of 
outdated erythrocytes and description of the candle jar method. J. 
Parasitol., 63(5): 883-886. 
Khan MO, Levi MS, Tekwani BL, Khan SI, Kimura E, Borne RF (2009). 
Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline 
Analogs. Antimicrob. Agents Chemother., 53(4): 1320-1324.  
Marshall S (1998). Zinc gluconate and common cold: review of 
randomized controlled trials. Can. Fam. Phys., 4: 1037-1042. 
Muller O, Becher H, Van Zweeden AB (2001).  Effect of Zinc 
supplementation on malaria and other causes of mobidity in West 
African children: randomized, double blind, placebo controlled trial. 
Br. Med. J., 123:  234-242.  
Obaleye JA, Tella AC, Arise RO (2009). In Vivo Antimalarial Activity and 
Toxicological Studies of Some Quinoline Methanol Metal Complexes. 
Adv. Nat. Appl. Sci. Adv. Nat. Appl. Sci., 3(1): 43-48.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ogunlana et al.          519 
 
 
 
Ogunlana OO, Ogunlana OE, Ademowo OG (2009). Comparative in 
vitro assessment of the antiplasmodial activity of quinine-zinc 
complex and quinine sulphate. Sci. Res. Essays,  4(3): 180-184.  
Olliaro P, Nevill C, LeBras J (1996). Systematic review of amodiaquine 
treatment in uncomplicated malaria. Lancet, 348: 1196-1201.  
Phillipson JD (1991). Assays for antimalarial and amoebicidal activities. 
Hostettmann, K. (Ed.). Methods in plant biochemistry 6, Academic 
Press Limited, Great Yarmouth, Norfolk, pp. 135-152. 
Sachs J, Malaney P (2002). The economic and social burden of 
malaria. Nature, 415(7): 680-685. 
Sandstead HH (1995). Requirement and toxicity of essential trace 
elements, illustrated by zinc and copper. Am. J. Clin. Nutr., 16: 6215-
6245.  
Trager W, Jenson JB (1976). Human malarial parasite in continuous 
culture. Science, 193:  673-675. 
World Health Organisation (1990). In vitro micro-test (Mark II) for the 
assessment of response Plasmodium falciparum to chloroquine, 
mefloquine, sulfadoxine, pyrimethamine, amodiaquine, pp. 1-21. 
 
 
